Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 has been added to the study's record history, and the older entry v3.5.3 has been removed. This update reflects an adjustment to the visible version history of the record rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-21T17:18:27.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the record history. The previous revision v3.5.2 was removed from the list.
    Difference
    0.1%
    Check dated 2026-04-30T04:17:31.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page updates its displayed software revision from v3.5.0 to v3.5.2. No trial-specific content changes are shown.
    Difference
    0.1%
    Check dated 2026-04-22T18:25:19.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added a new version entry: Revision: v3.5.0, and removed the entry: Revision: v3.4.3, in the study record history.
    Difference
    0.1%
    Check dated 2026-03-25T01:36:06.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-10T14:40:56.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.4.2) and removal of the previous revision (v3.4.1); this is metadata about page revisions and does not alter study information or display.
    Difference
    0.1%
    Check dated 2026-02-17T03:23:42.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.